MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA. (12th June 2019) - Cheminant, M.; Lhermitte, L.; Bruneau, J.; Sicard, H.; Bonnafous, C.; Ortonne, N.; Genestier, L.; Gaulard, P.; Palmic, P.; Dussiot, M.; Waast, L.; Avettand‐Fenoel, V.; et al.